Can-Fite BioPharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CANF and other ETFs, options, and stocks.About CANF
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602.
CEOMotti Farbstein
CEOMotti Farbstein
Employees5
Employees5
HeadquartersRamat Gan, HaMerkaz
HeadquartersRamat Gan, HaMerkaz
Founded1994
Founded1994
Employees5
Employees5
CANF Key Statistics
Market cap6.68M
Market cap6.68M
Price-Earnings ratio-0.25
Price-Earnings ratio-0.25
Dividend yield—
Dividend yield—
Average volume37.20K
Average volume37.20K
High today$3.12
High today$3.12
Low today$2.90
Low today$2.90
Open price$2.98
Open price$2.98
Volume23.47K
Volume23.47K
52 Week high$36.40
52 Week high$36.40
52 Week low$2.90
52 Week low$2.90
CANF News
TipRanks 4d
Can-Fite and Vetbiolix Complete Phase 2 Enrollment for Canine Osteoarthritis Drug PiclidenosonUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
TipRanks 4d
Can-Fite BioPharma completes enrollment in Piclidenoson studyCan-Fite BioPharma (CANF) announced that its veterinary partner Vetbiolix has completed enrollment in a Phase 2 study of Piclidenoson for the treatment of osteo...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.